US · Healthcare

Lonza Group Ltd (LZAGF)

Diagnostics & Research

Lonza Group Ltd (LZAGF) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LZAGF

P/E ratio

18.00

Lonza Group Ltd (LZAGF) — FAQ

What is LZAGF's P/E ratio?

The price-to-earnings (P/E) ratio for Lonza Group Ltd (LZAGF) is 18.00 (data as of 2026-05-23).

Does Lonza Group Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Lonza Group Ltd (LZAGF). Check the MyAverix Finance app for the latest dividend data.

What sector is Lonza Group Ltd in?

Lonza Group Ltd (LZAGF) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is LZAGF listed on?

LZAGF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)